Nalbuphine HCl Injection, 20 mg/mL, 10 mL Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lak...

FDA Drug Recall #D-096-2013 — Class II — November 21, 2012

Recall Summary

Recall Number D-096-2013
Classification Class II — Moderate risk
Date Initiated November 21, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Hospira, Inc.
Location Lake Forest, IL
Product Type Drugs
Quantity 145,400 vials

Product Description

Nalbuphine HCl Injection, 20 mg/mL, 10 mL Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1467-01

Reason for Recall

Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured.

Distribution Pattern

Nationwide and Puerto Rico.

Lot / Code Information

Lot #: 11-293-DK, Exp 05/01/13

Other Recalls from Hospira, Inc.

Recall # Classification Product Date
D-1815-2015 Class II 1% Lidocaine HCl Injection, USP, 10 mg/mL, 30 m... Aug 25, 2015
D-1234-2014 Class I 1% Lidocaine HCl Injection, USP, 10 mg/mL, NDC ... Sep 16, 2013
D-023-2014 Class II Morphine Sulfate Injection, USP, (25mg/mL), 250... Sep 16, 2013
D-926-2013 Class II Ketorolac Tromethamine Inj., USP, 30 mg vial, R... Aug 12, 2013
D-851-2013 Class II Ondansetron Injection, USP, 4mg/2mL, (2mg/ml), ... May 20, 2013

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.